Avid Radiopharmaceuticals, Inc. to Present at Oppenheimer 20th Annual Healthcare Conference on November 3rd

PHILADELPHIA--(BUSINESS WIRE)--Avid Radiopharmaceuticals, Inc., a leader in the development of products with the potential for earlier and more effective detection, diagnosis and monitoring of brain disorders, today announced that Daniel M. Skovronsky, M.D., Ph.D., Founder and CEO, will present at the Oppenheimer 20th Annual Healthcare Conference on Tuesday, November 3, 2009 at 1:00pm ET in the Louis XVI Room at the Waldorf=Astoria in New York, NY.